Search Results - "Tan, Tuan Zea"

Refine Results
  1. 1

    ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia by Zhou, Jianbiao, Yiying Quah, Jessie, Ng, Yvonne, Chooi, Jing-Yuan, Hui-Min Toh, Sabrina, Lin, Baohong, Zea Tan, Tuan, Hosoi, Hiroki, Osato, Motomi, Seet, Qihui, Ooi, Lisa A G, Lindmark, Bertil, McHale, Mark, Chng, Wee-Joo

    Published in Haematologica (Roma) (01-09-2020)
    “…Differentiation therapies achieve remarkable success in acute promyelocytic leukemia, a subtype of acute myeloid leukemia. However, excluding acute…”
    Get full text
    Journal Article
  2. 2
  3. 3

    BET Bromodomain inhibition promotes De-repression of TXNIP and activation of ASK1-MAPK pathway in acute myeloid leukemia by Zhou, Yafeng, Zhou, Jianbiao, Lu, Xiao, Tan, Tuan-Zea, Chng, Wee-Joo

    Published in BMC cancer (11-07-2018)
    “…Targeted therapy has always been the focus in developing therapeutic approaches in cancer, especially in the treatment of acute myeloid leukemia (AML). A new…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The role of GRHL2 and epigenetic remodeling in epithelial–mesenchymal plasticity in ovarian cancer cells by Chung, Vin Yee, Tan, Tuan Zea, Ye, Jieru, Huang, Rui-Lan, Lai, Hung-Cheng, Kappei, Dennis, Wollmann, Heike, Guccione, Ernesto, Huang, Ruby Yun-Ju

    Published in Communications biology (24-07-2019)
    “…Cancer cells exhibit phenotypic plasticity during epithelial–mesenchymal transition (EMT) and mesenchymal–epithelial transition (MET) involving intermediate…”
    Get full text
    Journal Article
  6. 6

    SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2 by Sundararajan, Vignesh, Tan, Ming, Zea Tan, Tuan, Pang, Qing You, Ye, Jieru, Chung, Vin Yee, Huang, Ruby Yun-Ju

    Published in Cancers (02-05-2020)
    “…Over two decades of research on cancer-associated epithelial-mesenchymal transition (EMT) led us to ascertain the occurrence of transitional intermediate…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK by Chen, Ru-Mei, Chiou, Yi-Shiou, Chong, Qing-Yun, Poh, Han-Ming, Tan, Tuan-Zea, Zhang, Meng-Yi, Ma, Lan, Zhu, Tao, Pandey, Vijay, Basappa, Kumar, Alan Prem, Lobie, Peter E

    “…Increased expression of trefoil factor 3 (TFF3) has been reported in colorectal carcinoma (CRC), being correlated with distant metastasis and poor clinical…”
    Get full text
    Journal Article
  10. 10

    The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions by Davidson, Ben, MD PhD, Holth, Arild, BSc, Hellesylt, Ellen, MSc, Tan, Tuan Zea, PhD, Huang, Ruby Yun-Ju, MD PhD, Tropé, Claes, MD PhD, Nesland, Jahn M., MD PhD, Thiery, Jean Paul, PhD

    Published in Human pathology (01-01-2015)
    “…Summary We recently identified gene signatures that allow classification of ovarian carcinoma into 5 distinct clinically relevant groups. In the present study,…”
    Get full text
    Journal Article
  11. 11

    E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial- mesenchymal transition in bladder carcinoma by Gondkar, Kirti, Patel, Krishna, Krishnappa, Shobha, Patil, Akkamahadevi, Nair, Bipin, Sundaram, Gopinath Meenakshi, Zea, Tan Tuan, Kumar, Prashant

    “…Transcription factors are commonly deregulated in various cancers. Here, we evaluated role of ELF3 in pathogenesis of bladder carcinoma (BCa). We confirmed…”
    Get more information
    Journal Article
  12. 12

    LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell-like Transcriptional Program in AML by Zhou, Jianbiao, Chan, Zit-Liang, Bi, Chonglei, Lu, Xiao, Chong, Phyllis S Y, Chooi, Jing-Yuan, Cheong, Lip-Lee, Liu, Shaw-Cheng, Ching, Ying Qing, Zhou, Yafeng, Osato, Motomi, Tan, Tuan Zea, Ng, Chin Hin, Ng, Siok-Bian, Wang, Shi, Zeng, Qi, Chng, Wee-Joo

    Published in Molecular cancer research (01-03-2017)
    “…PRL-3 (PTP4A3), a metastasis-associated phosphatase, is also upregulated in patients with acute myeloid leukemia (AML) and is associated with poor prognosis,…”
    Get full text
    Journal Article
  13. 13

    Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C-Mutant Non-Small Cell Lung Cancer by Adachi, Yuta, Ito, Kentaro, Hayashi, Yuko, Kimura, Ryo, Tan, Tuan Zea, Yamaguchi, Rui, Ebi, Hiromichi

    Published in Clinical cancer research (15-11-2020)
    “…is among the most commonly mutated oncogene in cancer including non-small cell lung cancer (NSCLC). In early clinical trials, inhibitors targeting G12C-mutant…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Dual role of autophagy in hallmarks of cancer by Singh, Shikha Satendra, Vats, Somya, Chia, Amelia Yi-Qian, Tan, Tuan Zea, Deng, Shuo, Ong, Mei Shan, Arfuso, Frank, Yap, Celestial T., Goh, Boon Cher, Sethi, Gautam, Huang, Ruby Yun-Ju, Shen, Han Ming, Manjithaya, Ravi, Kumar, Alan Prem

    Published in Oncogene (01-03-2018)
    “…Evolutionarily conserved across eukaryotic cells, macroautophagy (herein autophagy) is an intracellular catabolic degradative process targeting damaged and…”
    Get full text
    Journal Article
  16. 16

    Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients by Tan, Tuan Zea, Miow, Qing Hao, Miki, Yoshio, Noda, Tetsuo, Mori, Seiichi, Huang, Ruby Yun‐Ju, Thiery, Jean Paul

    Published in EMBO molecular medicine (01-10-2014)
    “…Epithelial‐mesenchymal transition (EMT) is a reversible and dynamic process hypothesized to be co‐opted by carcinoma during invasion and metastasis. Yet, there…”
    Get full text
    Journal Article
  17. 17

    A Novel Biologically and Psychologically Inspired Fuzzy Decision Support System: Hierarchical Complementary Learning by Tan, Tuan Zea, Ng, Geok See, Quek, Chai

    “…A computational intelligent system that models the human cognitive abilities may promise significant performance in problem learning because a human is…”
    Get full text
    Journal Article
  18. 18

    The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200 by Noman, Muhammad Zaeem, Janji, Bassam, Abdou, Abderemane, Hasmim, Meriem, Terry, Stéphane, Tan, Tuan Zea, Mami-Chouaib, Fathia, Thiery, Jean Paul, Chouaib, Salem

    Published in Oncoimmunology (02-01-2017)
    “…PD-L1 expression and regulation by mesenchymal tumor cells remain largely undefined. Here, we report that among different EMT-activated MCF7 human breast…”
    Get full text
    Journal Article
  19. 19

    Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis by Datta, Arpita, Deng, Shuo, Gopal, Vennila, Yap, Kenneth Chun-Hong, Halim, Clarissa Esmeralda, Lye, Mun Leng, Ong, Mei Shan, Tan, Tuan Zea, Sethi, Gautam, Hooi, Shing Chuan, Kumar, Alan Prem, Yap, Celestial T

    Published in Cancers (14-04-2021)
    “…In cancer cells, a vital cellular process during metastasis is the transformation of epithelial cells towards motile mesenchymal cells called the epithelial to…”
    Get full text
    Journal Article
  20. 20

    SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition by Sundararajan, Vignesh, Tan, Ming, Tan, Tuan Zea, Ye, Jieru, Thiery, Jean Paul, Huang, Ruby Yun-Ju

    Published in Scientific reports (05-06-2019)
    “…Aberrant activation of epithelial to mesenchymal transition (EMT) associated factors were highly correlated with increased mortality in cancer patients. SNAIL…”
    Get full text
    Journal Article